ecrin-mdr-crcClinical2016Malignant neoplasm of rectosigmoid junctionMalignant neoplasm of colonMalignant neoplasm of rectumMalignant Neoplasm Of RectumMalignant Neoplasm Of Rectosigmoid JunctionMalignant Neoplasm Of ColonObservationalhttps://newmdr.ecrin.org/Study/2431545Germany2ECRIN MDROtherfalseProspective non-interventional double study about gender specific differences in the treatment of colorectal cancer - Version: Treatment with Irinotecan containing regimens LIV PharmaInterventions: Group 1: This non-interventional study is observing a patient population with histologically or cytologically diagnosed colorectal cancer, for which the treatment with Irinotecan LIV Pharma is indicated according to SPC There are the special warnings and precautions for use in the SPC of Irinotecan LIV to be addressed. Primary outcome(s): Efficacy and Tolerability routine practice. Observational, non-interventional study. In detail: Was therapy completed as planned and what was the response. Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment2016-02-152431545DRKS00009342U1111-1174-0930